carpal tunnel syndrome. Carpal tunnel syndrome, unspecified upper limb
Conditions
Interventions
Intervention group two was treated with carpal bone and Median nerve mobilization at wrist for ten sessions, every other day
also received wrist splint with oral medication (Gabapentin tablet 100 mg and Vitamin B6 tablet 40 mg per day) for two month.Intervention group:.
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Carpal tunnel syndrome approved by electrodiagnostic criteria Age 30 to 60 years old and with any sex
Exclusion criteria
Exclusion criteria: Atrophy of tenar muscle, mild or severe CTS based on electrodiagnostic study patient who was treated with anti-inflammatory drugs or physiotherapy modalities previous local steroids injection in a recent year or previous surgery for CTS Inflammatory joint disease, diabetes mellitus, thyroid disease Polyneuropathy, cervical radiculopathy, myelopathy Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Electrodiagnostic parameters of Median nerve (sensory and motor latency and amplitude). Timepoint: Before and two months after treatment. Method of measurement: By electrodiagnostic device (Medtronic Dk-2740 denmark). | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Before, one and two months after treatment. Method of measurement: By visual analogue scale.;Symptom severity and functional status. Timepoint: Before, one and two months after treatment. Method of measurement: By Boston carpal tunnel questionnaire.;Patient satisfaction. Timepoint: 6 months after treatment. Method of measurement: By telephone. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamideh Dehghani
Artesh University of Medical Sciences
Outcome results
None listed